global messaging alerts

Expert Content Library "The Globe"

"The Globe" offers insight on issues that impact global health from ApiJect's Global Health team.

Impacting Global Health

  • July 9, 2024

    “Vaccine Delivery Struggles”
    Vaccines and vaccination are often in the news – perhaps never more than in the last four years, as the world found its way through the COVID pandemic. They were high on the agenda of the recent World Health Assembly, held last month in Geneva, with encouraging stories of vaccination campaign successes, and frustrating stories of vaccination obstacles and unrealized hopes.

  • June 25, 2024

    Mark KamauIn the most recent installment of “From the Front Line,” Paul Rutter, MD chats with Mark Kamau, a human-centered designer residing in Nairobi. Mark specializes in designing products tailored to African and emerging markets, prioritizing user engagement and context to ensure that these products effectively serve their intended purposes.

  • April 30, 2024

    Pharma Partner Introducing New Sterile Vaccine Product

    HIPRA, an EU-based biopharma company, was developing a recombinant protein vaccine against SARS-COV-2 and was looking for an experienced partner to work with in order to improve the adoption of its vaccine in global markets.

  • April 18, 2024

    Carles Fàbrega and Ed Kelley discuss the One Health agenda in this episode, which goes beyond the usual global health topics. One Health focuses on the connection between human and animal health and its implications for issues like antimicrobial resistance, vaccine development, and epidemics in the future.

  • March 12, 2024
    From the Front Line Podcast We’re excited to have Heidi Larson, PhD, Founding Director of the Vaccine Confidence Project. She has also headed Global Immunization Communication at UNICEF. She’s an author recognized as one of BBC’s 100 Women of 2021, and a senior advisor to ApiJect.
  • March 1, 2024

    Offering Access to Injectable Medicines: The Prefilled ApiJect Injector

  • March 1, 2024

    Test Drive Our Technology

  • March 1, 2024

    A Novel Prefilled Drug Delivery Platform: Expanding Access and Distribution

  • March 1, 2024

    Meet PJ Kim

  • February 13, 2024

    The Globe: The Intersection of Healthcare & Conflict“The Intersection of Healthcare and Conflict”

    Today, the world is facing the highest number of violent conflicts since the Second World War. According to the United Nations, 2 billion people — a quarter of humanity — live in places affected by such conflict

  • December 24, 2023
    In the first episode, Dr. Kelley is joined by global health pioneer, Michael Free, PhD, OBE. Michael Free retired from PATH where he held the position of vice president and senior advisor for technologies. He was the global program leader for Technology Solutions, which included assessment of need, technology development and transfer, global introduction, development of international standards, program planning and management, and policies. 
  • October 30, 2023

    The Globe Newsletter: AI“Faster and Better-How AI is Reshaping Vaccines and Medication Research”

    Artificial Intelligence (AI) promises to increase the efficiency of care as systems strive towards these goals. 

  • October 17, 2023

    Sterile Fill-Finish Market & Technology Trends

    ApiJect expert discusses sterile fill-finish market trends and ApiJect’s platform technology.

  • October 9, 2023

    Accelerating Access: The Future of Prefilled and Plastic
    Learn more about the need for greater fill-finish capacity in the pharmaceutical industry highlighted by the pandemic, and how the Prefilled ApiJect Injector platform aims to meet this need.

  • August 8, 2023

    Making Medical Injections Safe and Accessible

    Anchored by two well-known medical technologies – BFS fill-finish and high precision injection molding – ApiJect’s novel drug delivery platform offers safety, cost, supply chain, and eco advantages over existing devices. Learn more with this interview with Jon Ellenthal, President at ApiJect.

  • July 17, 2023

    Pet Owners and Small Farms Worldwide Need New and Better Medical Injection Options to Keep Their Animals Healthy
    Animal health and human health are closely linked. At home, healthy pets make happier, longer-lived companions. On farms, sick animals put human health at risk, while healthier livestock reduces the spread of disease and produces safer food.

  • July 17, 2023

    When Injections Spread Disease
    Worldwide use of contaminated vials and syringes in clinical settings leads to 1.3 million deaths per year…and spreads disease to millions.

  • July 17, 2023

    Blow-Fill-Seal Prefilled Injectors Support Many Use Cases for Global Impact
    An affordable, single-use prefilled injector* could open new opportunities for coverage, access, and equity for billions of people around the world.

  • July 5, 2023

    “Revolutionizing Prefilled Injectables through Innovative Technology”
    Learn how scalable fill-finish, a compact supply chain, and cost-efficient manufacturing can solve drug delivery challenges for prefilled injectables.

    As the demand for parenteral products increases, companies are seeking solutions that offer the benefits of prefilled formats while reducing lead times and costs associated with sterile fill-finish services. The projected growth of sterile injectables in the next decade makes finding such solutions crucial. Aseptic manufacturing technology combined with injection molding offers a more flexible and resilient supply chain, even during global crises such as the COVID-19 pandemic.

    In this webinar, a case study will be presented that showcases the advancement of product design based on customer needs, especially in the context of injectables. The study will demonstrate the progression from using multi-dose glass vials to single-dose prefilled injectors, and how this evolution aligns with the future of technology being in plastic. The speakers will emphasize the logical progression with a focus on integrating quality, convenience and safety into innovative technology. The FDA has outlined key considerations for transitioning to innovative combination products which will also be discussed. By following a device development approach, a modular and customizable design can be achieved, offering endless possibilities for creating the appropriate drug delivery solution.

    • Identify critical factors to consider when transitioning from a vial to a combination product and how to navigate the challenges involved in this process
    • Learn about the next-generation advanced aseptic fill & finish technology for prefilled single-dose sterile injectables and its impact on the pharmaceutical industry
    • Explore the history of injectables and the changing demands of customers for enhanced drug delivery systems
    • Discover key considerations when transitioning from vials to combination products and strategies to overcome associated challenges


    • Tony Wasilewski, Vice President, Pharmaceutical Development Services, ApiJect Systems, Corp.
    • Lauren Greenberg, Vice President, Device Development, ApiJect Systems, Corp.
  • July 5, 2023

    Joe Wojcik
    How does ApiJect ensure that the temperature changes which occur during BFS manufacturing do not negatively impact the drug product? Can Blow-Fill-Seal handle ultra-low temperatures? Can Blow-Fill-Seal be used for vaccines?

  • June 29, 2023

    The Globe - Medical Drones“Crossing the Last Mile: Delivery Systems”

    After the surge in medical technological advancements brought on by the COVID-19 pandemic and shift toward digital innovations in healthcare, we may find ourselves asking, what’s next?

  • June 29, 2023

    Flora Koska-Medical Waste Article“An Insight into the Repercussions of Medical Waste and its Disposal”

    A safe injection does not guarantee safety for a community unless disposed of correctly. This article aims to address a topic which is by no means novel but is often overlooked when considering safety issues surrounding injections: safe disposal and afterlife of medical waste.

  • June 20, 2023

    Joe Wojcik
    Temperature is everyone’s first question. How does temperature play a major role? Does the heat affect the drug product? How is the temperature controlled?

  • June 12, 2023

    Component Supply Chain
    Josh Myers, MBA
    Are polymers readily available? Does ApiJect stockpile resin/polymer? What manufacturing capacity does ApiJect have available today?

  • June 6, 2023

    Prefilled Injectors
    Dave Boerschel
    How do you prevent “suck-back” where blood is drawn into containers? Is a prefilled syringe the same as an auto-injector?

  • May 31, 2023

    ”Self-care and the Rapidly Changing Market of Obesity Drugs”

    Could anti-obesity drugs recently approved by the FDA and other regulators make a difference in one of the world’s biggest public health challenges?

  • May 15, 2023

    Injector Components
    Josh Myers, MBA
    What are the components of the prefilled injector? Does the needle hub also have components? What Type of plastic is used on the container, hub, and components?

  • May 1, 2023

    Special Feature: Parenteral Drug Delivery: Could a Dose of AI Improve Development?

    Drug Development & Delivery, Issue: May 2023

    While the industry is just at the precipice of discovering what AI can do for injectable delivery, this exclusive Drug Development & Delivery annual report highlights the strides that companies are currently making toward improving dose accuracy, integrating design safety, and accelerating time to market.

  • May 1, 2023

    Component Manufacturing
    Josh Myers, MBA
    Who manufactures ApiJect’s components? What is manufactured at TRC? What about Fareva?

  • April 15, 2023

    Pharmaceutical Packaging 2
    Jon Burgess
    Are any of those packaging functions trade-offs, or are they all complimentary? Have there been major advances in packaging in the last, say ten years?

  • April 12, 2023

    “The End of COVID-19? Not for Everybody.”

    We are now entering our fourth spring of the global COVID pandemic. But this spring looks far different from the last three. April of 2020 saw the world…

  • March 30, 2023

    “The Long Road with Long COVID”

    With infections dropping, COVID-19 seems to have become obsolete. What’s next?

  • March 29, 2023

    Pharmaceutical Packaging
    Jon Burgess
    What logistical challenges arise concerning the supply chain management for different packaging materials? What are the road tests that a glass or plastic vial must pass for pharmaceutical use?

  • March 20, 2023

    Inside the Machine Shop: Flame Welding

  • March 20, 2023

    Inside the Machine Shop: Mold Grinding 2

  • March 20, 2023

    Inside the Machine Shop: Spark Welding

  • March 20, 2023

    Inside the Machine Shop: Prototype Mold Cutting 2

  • March 20, 2023

    Unlocking Blow-Fill-Seal for Injectables

  • March 15, 2023

    Partnering: Pharma Companies
    Reimagining Injectable Drug Solutions. At ApiJect, our experts work with your team to design BFS-based prefilled drug delivery systems for your drug product.

  • March 14, 2023

    Handling Drug Product
    Joe Wojcik
    What formulations can ApiJect handle? What about nitrogen overlay? Describe ApiJect’s end-to-end development capabilities to ensure the right device is created.

  • March 2, 2023

    Prefilled ApiJect Injector*—0.5mL Delivery

  • March 2, 2023

    Elements of the Prefilled ApiJect Injector

  • February 24, 2023

    Five Functions of Packaging
    Jon Burgess
    What are the five functions of pharmaceutical packaging?

  • February 22, 2023

    “When Business as Usual is Bad for Public Health”

    In January 2023, the U.S. FDA announced its plans for the future of COVID vaccination. COVID vaccines will follow the path…               

  • February 20, 2023

    Meet Stephanie Summe, Sr. Director, Device Development

  • February 17, 2023

    Meet Molly Weaver, PhD, Chief Technology Officer

  • February 17, 2023

    Prefilled Injector Supply Chain
    Dave Boerschel
    How does BFS perform in sterility and particulate matter requirements?, Why can BSF containers be harder to physically inspect?, How many BFS containers would be inspected? and Is human visual inspection ever supplemented with machine photography and analysis?

  • February 15, 2023

    The Field Research Network was created to gather qualitative and quantitative data from real-world settings through ground level investigations, particularly in low- and middle-income countries. Resulting information helps ApiJect engineers develop medical devices for all global markets.

  • January 18, 2023

    Blow-Fill-Seal Container Inspection
    Philip Leslie
    How does BFS perform in sterility and particulate matter requirements?, Why can BSF containers be harder to physically inspect?, How many BFS containers would be inspected? and Is human visual inspection ever supplemented with machine photography and analysis?

  • January 3, 2023

    Pharmaceutical Packaging Standards (Pt. 1)
    Jon Burgess
    What have been the industry standards in packaging? and Who sets these industry standards?

  • December 12, 2022

    Blow-Fill-Seal Terminal Sterilization
    Philip Leslie
    What is the difference between conventional terminal sterilization and bulk sterilization?; With terminal, what other methods are used besides heat?; Has there ever been a time where terminal was used with BFS, or when it’s desirable?; What kind of equipment/space is needed? and With BFS, is sterilization always done on site?

  • November 30, 2022

    Drug Stability Testing & Formulation
    Joe Wojcik
    How is drug stability maintained during BFS fill-finish?; Is the drug mixing done onsite, or at the pharmaceutical supplier?; How is stability testing handled?; What are ApiJect’s formulation capabilities? and In addition to viscous products, what are the other formulation challenges?

  • November 7, 2022

    Launch of Did You Know: Blow-Fill-Seal
    Molly Weaver, PhD

    Short, technical Q&A videos where ApiJect experts provide responses to questions about BFS technology. Such as, “How does BFS handle light and oxygen sensitive drug products?” and “Does BFS manufacturing create less pollution and waste byproduct volume than glass?”

  • November 1, 2022

    “Vaccines Beyond COVID-19”

    mRNA technology was launched originally not for COVID-19 but for personalized vaccines for chronic diseases like cancer. Can we do a better job this…

  • October 24, 2022

    “From Measles to Malaria- Case for Building Delivery into Development for Vaccines & Drugs”

  • October 14, 2022

    Live with Chaudhrey: Paul Rutter, MD At the World Vaccine Congress Europe. Paul shares insight on building delivery into the development of vaccines and injectables.

  • October 10, 2022

    Blow-Fill-Seal has a Compact Supply Chain

  • October 10, 2022
  • October 10, 2022

    Blow-Fill-Seal for Sterile Liquids, Biologics and Potent Compounds

  • October 10, 2022

    Blow-Fill-Seal is Advancing Fill-Finish & Injection Technology

  • September 12, 2022

    Chats with Chaudhrey: “Prototype Mold Making for BFS Processes”, Jon Burgess
    Rizwan chats with Jon to learn more about ApiJect’s recently opened Technology Development Center in Florida and prototype mold making for Blow-Fill-Seal processes.

  • September 1, 2022

    “Leading After Emergency”

    After pages of goals and recommendations on responding to COVID-19 and preparing for the next pandemic, one thing is still lacking: leadership.

  • August 29, 2022

    Filling Tests on Rommelag Bottlepak 434 Pt. 2

  • August 29, 2022

    The Benefits of Plastic Injection Molding
    Using the latest in Injection Molding Tooling innovations, components can prototyped to a production quality level.

  • August 29, 2022

    Filling Tests on Rommelag Bottlepack 434 Pt. 3

  • August 29, 2022

    Filling Tests on Rommelag Bottlepak 434 Pt. 1

  • August 25, 2022

    “Solving “Impossible” Problems Starts Here”

    The chasm between the West and rest on healthcare quality and access seems insoluble. But we can narrow the gap.

  • August 18, 2022

    Overview of Blow-Fill-Seal Manufacturing and Secondary Packaging Line

  • August 12, 2022

    Inside the Machine Shop: Prototype Mold Cutting

  • August 12, 2022

    Inside the Machine Shop: Prototype Mold Grinding

  • August 11, 2022

    Fill-Finish Podcast 6 – “Current State and Trends Impacting Fill-Finish from Formulation through Commercialization”


    • Guest: Parrish Galliher, Independent Bioprocess Consultant
    • Hosted by: Rizwan Chaudhrey
  • August 5, 2022

    ApiJect Platform Uses Efficient BFS Manufacturing Processes

  • August 5, 2022

    Blow-Fill-Seal Creates and Fills a Container in a Continuous Process

  • August 4, 2022

    “On Polio, Monkeypox, and COVID-19”

    The Lessons We Can, and Cannot, Take

  • July 19, 2022

    “The Most Important Faces in Global Health”

    They are the children that modern medicine forgot, or utterly failed to reach.

  • June 29, 2022

    How Blow-Fill-Seal Delivers Operational Efficiencies and Aseptic Fill-Finish
    with Joe Wojcik, Senior Director, Pharmaceutical Development Services

    Pharma expert, Joe Wojcik, discusses the technical factors and requirements that make BFS an “advanced aseptic process” for fill-finish, and why BFS has relatively low capital requirements

  • June 26, 2022

    “Turning Obstacles into Assets”

    Seeking to improve global health access? Learn to leverage limits and constraints as springboards for innovation

  • June 23, 2022

    Fill-Finish Podcast 5 – “Temperature Sensitive Biologics and Blow-Fill-Seal”


    • Guest: Philip Leslie, Acting Head of Manufacturing, ApiJect
    • Hosted by: Rizwan Chaudhrey
  • June 21, 2022

    “How Global is Global Health?”

    Traditional funding streams continue to favor northern institutions. Is it time to change?

  • June 16, 2022

    “Behind the Headlines”

    Very few people had heard of monkeypox a month ago. Now – despite tough competition from other major global events…

  • June 15, 2022

    Fill-Finish Podcast 4 – “Evolving Trends in Aseptic Processing”


    • Guest: Len Pauzer, President, Pauzer Consulting
    • Hosted by: Rizwan Chaudhrey
  • May 24, 2022

    “Are genetically modified mosquitos the solution to malaria?”

    Thinking about known-unknowns and unknown-unknowns.

  • May 16, 2022

    “Hidden in Plain Sight”

    Why Unsafe Injections Remain a Global Challenge

  • May 6, 2022

    “Production For the Last Mile”

    We have plenty of COVID vaccines and doses. The real challenge now is delivering them the last mile.

  • April 29, 2022

    “Sometimes There is an Obvious Solution”

    Problem: not enough doctors and nurses; millions of people to vaccinate. Solution: let Community Health Workers do it.

  • April 26, 2022

    Technology Development Center
    The ApiJect Technology Development Center in greater Orlando, Florida is focused on helping pharmaceutical companies prepare their drug product for high-speed, high-volume production in a new type of scalable prefilled syringe that is made largely using the Blow-Fill- Seal aseptic process.

  • April 25, 2022

    “What are the real COVID mortality numbers?”

    Estimates from WHO are pending; meanwhile a study in The Lancet suggests the true number of global fatalities from COVID may be 3x higher than indicated…

  • April 22, 2022

    Episode 4: “Evolving Trends in Aseptic Processing”*


    • Guests: Len Pauzer, President, Pauzer Consulting
    • Hosted by: Rizwan Chaudhrey
  • April 20, 2022

    We’ve Lost a Giant”

    Dr. Paul Farmer led by personal example and total commitment. Here are 3 secrets that made him incredibly inspiring – and effective.

  • April 14, 2022

    Fill-Finish Podcast 3 – “Global Supply Chain Management and Capacity Planning”


    • Guest: Omair Ahmed, Chief Strategy Officer, Nexus Pharmaceuticals
    • Hosted by: Rizwan Chaudhrey
  • April 8, 2022

    Join the ApiJect team! We’re always looking for passionate teammates.

    We envision a world where every country can safely, locally, and cost-effectively package and deliver all of the essential injectable medicines and vaccines its citizens need to live long, healthy lives.

  • April 7, 2022

    Global Manufacturing Supply Chain Resiliency

    We have created a compact and flexible supply chain that can be almost entirely domestic in major markets. This is because we rely on two robust manufacturing technologies to make our platform: Blow-Fill-Seal (BFS) aseptic filling and plastic injection molding.

  • April 3, 2022

    Chapter 35: How to Get Started with Blow-Fill-Seal

  • April 2, 2022

    Chapter 34: – BFS Delivery System Approach

  • April 1, 2022

    Chapter 33 Temperature Management

  • April 1, 2022

    Chapter 32: The Use of Foil Wrap in Blow-Fill-Seal

  • March 31, 2022

    Chapter 31: Particulate Inspection in Blow-Fill-Seal

  • March 30, 2022

    Chapter 30: Leak Detection with Blow-Fill-Seal

  • March 29, 2022

    Chapter 29: Blow-Fill-Seal Punching, Engraving, and Separating

  • March 28, 2022

    Fill-Finish Podcast 2: “The Past, Present, and Future of Advanced Aseptic Facility Design”


    • Guests: Sterling Kline, RA, Vice President, Design and Jason Collins, AIA, Director of Process Architecture, IPS-Integrated Project Services
    • Hosted by: Rizwan Chaudhrey

  • March 28, 2022

    Chapter 28: Blow-Fill-Seal Machine and Support Systems

  • March 27, 2022

    Chapter 27: Areas of a Blow-Fill-Seal Line

  • March 26, 2022

    Chapter 26: Blow-Fill-Seal Molds

  • March 25, 2022

    Chapter 25: Blow-Fill-Seal Manufacturing Efficiencies

  • March 24, 2022

    Chapter 24: Blow-Fill-Seal CapEx and Fixed Costs

  • March 23, 2022

    Chapter 23: Blow-Fill-Seal Equipment

  • March 22, 2022

    Chapter 22: Space and Utilities Needed for Blow-Fill-Seal

  • March 21, 2022

    Chapter 21: Blow-Fill-Seal Filling Suite Installation

  • March 20, 2022

    Chapter 20: Sensitivity

  • March 19, 2022

    Chapter 19: Compatibility and Feasibility Testing with Blow-Fill-Seal

  • March 18, 2022

    Chapter 18: Cost Advantages of Blow-Fill-Seal

  • March 17, 2022

    Chapter 17: Flexible Scaling of Blow-Fill-Seal

  • March 16, 2022

    Chapter 16: Compact Supply Chain

  • March 15, 2022

    Chapter 15: Breakage Resistant

  • March 14, 2022

    Chapter 14: Transportation and Blow-Fill-Seal

  • March 13, 2022

    Chapter 13: High Productivity with the Blow-Fill-Seal Process

  • March 11, 2022

    Chapter 11: Blow-Fill-Seal’s Compact Manufacturing Footprint

  • March 10, 2022

    Chapter 10: BFS is a Cost-Efficient Manufacturing Process

  • March 9, 2022

    Chapter 9: Sterility Assurance

  • March 9, 2022

    ApiJect Prefilled Injector

    The Prefilled ApiJect Injector* is a delivery system designed to bring together the benefits of prefilled syringes with the manufacturing efficiency of multi-dose presentations. Watch the Video by clicking below.

  • March 9, 2022

    We are ApiJect
    We are a team of passionate and dedicated people. Our mission is to make injectable medicines and vaccines safe and accessible to everyone. Click the button below to watch the video.

  • March 9, 2022

    BFS Temperature Management

    Our BFS manufacturing experts employ a variety of techniques to consistently control the drug product’s temperature throughout the fill-finish process.

  • March 9, 2022


    Our experts marry the efficiency and flexibility of BFS with attachable plastic components to create drug delivery systems. This approach has the potential to enable scalable and efficient manufacturing of single-dose prefilled syringe which can typically only be found in multi-dose presentations.

  • March 9, 2022

    Partnering for Success

    We help pharma companies fill-finish sterile liquids by working together to create Blow-Fill-Seal based, prefilled drug delivery systems, and then assist in the fill-finish process. The result is a prefilled drug delivery system that can be flexibly manufactured at various facilities that use BFS.

  • March 9, 2022

    ApiJect Company Profile

    ApiJect is a medical technology company that seeks to improve how companies fill-finish injectable medicines. We do this by working with pharma partners to design rapidly-scalable drug delivery systems, and assist in manufacturing those devices at their facilities or a trusted CMO/CDMO.

  • March 8, 2022

    Chapter 8: Low Particulates Using Blow-Fill-Seal

  • March 7, 2022

    Chapter 7: Reliable Aseptic Filling

  • March 6, 2022

    Chapter 6: Advantages of Blow-Fill-Seal

  • March 5, 2022

    Chapter 5: Suitable Drug Products for BFS

  • March 4, 2022

    Chapter 4: Types of BFS Machines

  • March 3, 2022

    Chapter 3: How Blow-Fill-Seal Works

  • March 2, 2022

    Chapter 2: Blow-Fill-Seal in Pharma

  • March 1, 2022

    Chapter 1: What is Blow-Fill-Seal?

  • February 28, 2022

    Fill-Finish Podcast 1: “Current Trends in Isolation Technology and Vaccine Production”


    • Guest: Les Edwards, Vice President of Technology and Business Development, SKAN US
    • Host: Rizwan Chaudhrey

  • January 25, 2022

    Chats with Chaudhrey: “Fareva Licensing Agreement”. Jay Walker

    Rizwan chats with Jay, Executive Chairman at ApiJect, to learn more about ApiJect’s recent licensing agreement signed with Fareva to create a France-based 500M unit annual capacity for single-dose pre-filled vaccine injections.

  • December 9, 2021

    Project Profile: Fareva

    Increasing Vaccine Fill-Finish Capacity in France: 500M Unit Annual Capacity for Single-Dose Prefilled Vaccine Injectables

  • December 8, 2021

    Fierce Pharma: “Next Supply Chain Challenge: Syringes”

    An estimated 14 to 19 billion incremental injections will be required by year-end 2022 to vaccinate the world’s population against COVID-19 while supplying related boosters and adjuvants. In response, the industry is shifting billions of syringes from routine vaccinations and therapeutics to COVID, increasing existing capacity, and building new manufacturing sites for syringes. Yet COVID’s supply chain is still expected to fall short. What is the source of this looming shortage? Is “syringe nationalism” causing export embargoes? How is the industry responding? Is it a supply chain problem?

    In this webinar, three experts in pharma and global health discuss potential solutions including,

    • Onshoring of production
    • Increasing capacity in existing plants
    • Investing in new facilities
    • Need for Government funding of long-term supply chain infrastructure
    • Resources and technical know-how required for production
    • Need for trained local personnel to put “shots in arms”


    • Ed Kelley, PhD, Chief Global Health Officer, ApiJect
    • Omair Ahmed, Chief Strategy Officer, Nexus Pharmaceuticals
  • December 8, 2021

    What Have Been the Biggest Surprises with COVID-19?
    with Ed Kelley, PhD, Chief Global Health Officer

    The pandemic’s effects have been far more wide-reaching than many health officials expected, but COVID has also accelerated some positive trends.

  • November 9, 2021

    Advances in Sterile Liquids Packaging and Form Factors
    with Jon Burgess, General Manager, Technology Development Center

    Discussion on packaging factors that have led to wider acceptance of Blow-Fill-Seal technology in the pharmaceutical industry.

  • November 2, 2021

    Strengths of Diversity in Pharma
    with Amy Stewart, Chief People Officer

    Companies are realizing that a strong commitment to DEI and ESG attracts employees. Word of mouth is very powerful. Companies want to do business with partners that are inclusive with positive values and environmental initiatives.

  • October 15, 2021

    INTERPHEX Live 2021: “Creating a Sustainable Public Health Supply Chain”

    Industry experts share insights on how stakeholders can maintain a robust, resilient supply chain essential to global health and vaccine security, with an accelerated response time to meet the needs of current and future pandemics. The building blocks for this supply chain resiliency include tech transfer, designing for right-size capacity, improving operational efficiencies, implementing state-of-the-art technologies, and establishing regulatory and quality systems.


    •  Ed Kelley, PhD, former Director of Integrated Health Services for WHO and Chief Global Health Officer for ApiJect
    • Rob Roy, PE, Director of Aseptic Technology at IPS-Integrated Project Services
    • Paul Fisher, Director of Process Architecture at IPS-Integrated Project Services
    • Jim Fries, Chief Executive Officer, RX-360
  • October 15, 2021

    INTERPHEX Live 2021 Session: “Pros and Cons of Global Fill-Finish”

    Responding to the COVID-19 pandemic, governments and public health agencies worldwide are developing quality vaccine programs, including local fill-finish capacity, to support global immunization. Yet even before COVID, countries were already facing increased vaccine demand due to population growth. The panel will discuss key challenges and opportunities as governments and pharmaceutical manufacturers seek to establish fill-finish facilities around the world to enable access to greater and more diversified vaccine manufacturing while improving preparedness to respond to future pandemics.


    • Ed Kelley, PhD, former Director of Integrated Health Services for WHO; Chief Global Health Officer,  ApiJect
    • Jason Collins, AIA, Director of Process Architecture, IPS-Integrated Project Services
    • Omair Ahmed, Chief Strategy Officer, Nexus Pharmaceuticals
  • October 9, 2021

    Chats with Chaudhrey: “INTERPHEX 2021 Preview”, Josh Myers

    Rizwan chats with Josh last week to learn what ApiJect was doing at INTERPHEX 2021. Learn about our Technology Platform that brings together aseptic BFS with connectable components to create high-quality prefilled drug delivery systems

  • August 25, 2021

    Single-Dose Drug Delivery Fill-Finish Facility that is Scalable, Flexible, and able to Deliver up to 45M Units Per Month Delivered within an Accelerated Timeline of Fewer Than 7 Months
    Part 3

    ApiJect committed to creating emergency temporary fill-finish capacity for up to 45M doses a month of a candidate COVID-19 vaccine on BFS lines by the end of 2020. All of these BFS-packaged doses could then be used, if necessary, in ApiJect Prefilled Injectors for scalable, single-dose delivery.

  • August 24, 2021

    Solving Drug Challenges with Innovation, BFS, and a Technology Platform to Create Drug
    Delivery Systems
    Part 2

    Learn how ApiJect built its Technology Platform around BFS to create innovative drug delivery systems for the prefilled syringe market and other sterile liquid pharmaceutical delivery formats.

  • August 23, 2021

    BFS and Prefilled Syringes: A Solution for Complex Formulations
    Part 1

    Many countries, including the US, lack the necessary surge capacity to reliably fill-finish and deliver billions of incremental doses of injectable drugs and vaccines during bio-emergencies.

  • August 18, 2021

    Chats with Chaudhrey: “Syringe Reuse”, Edward Kelley, PhD

    Interesting chat with Edward Kelley, Chief Health Officer, ApiJect, and formerly the Head, Strategic Programs, at the World Health Organization about syringe reuse, the causes, impact, and how to help overcome it.

  • July 30, 2021

    The Surprising Strengths of Blow-Fill-Seal
    with Philip Leslie, Senior Advisor, Manufacturing
    Why does the FDA calls BFS an “advanced aseptic process”? How does BFS combine high-speed, economically efficient production with notable manufacturing flexibility? Respected industry veteran Philip Leslie explains “the basics of BFS.”

  • July 8, 2021

    Project Profile: The RiteDose Corporation

    In 2020, as part of the U.S. Government’s COVID-19 response, ApiJect™ entered into a long-term strategic partnership with The Ritedose Corporation (“TRC”). Together, they were able to make operational 45 million units per month of Blow-Fill-Seal fill-finish capacity for America’s COVID-19 response within 7 months out of TRC’s facility in Columbia South Carolina.

  • June 22, 2021

    Chats with Chaudhrey: “Blow-Fill-Seal”, Philip Leslie

    Rizwan chats with Philip to learn more about the advantages and which types of products can be made using BFS.

  • June 22, 2021

    Chats with Chaudhrey: “How to Progress your Products in BFS”, Philip Leslie

    Rizwans chats with Philip to learn more about the advantages and which types of products can be made using BFS.

  • June 9, 2021

    The ApiJect Story
    It turns out that Marc’s solution to the syringe safety problem has the potential to greatly improve how pharma companies fill, finish, and deliver their liquid medicines and vaccines across the board. Read more about Marc’s amazing journey by clicking the button below.

  • June 9, 2021

    ApiJect Prefilled Injector Assembly
    The ApiJect Prefilled Injector brings together an aseptically-filled Blow-Fill-Seal (BFS) container and a pen needle-style Needle Hub* to reliably deliver injectable vaccines and medicines. Click the button below to view the video.

  • May 9, 2021

    Special Feature: PFS & Parenteral Manufacturing: How COVID-19 Changed the Market
    Drug Development & Delivery, Issue: May 2021

    Worldwide, the parenteral market is seeing greater emphasis on patient safety. This is driving a strong trend to­ward unit-dose formats, including Blow-Fill-Seal pre­filled syringe, which are now the fastest-growing format for injectables.

  • March 9, 2021

    BFS Manufacturing Line
    What makes BFS truly special is its combination of reliable aseptic filling with its speed and efficiency of production for any size output. In fact, due to its enclosed process and reliability, the industry considers BFS to be an advanced aseptic process. To view the video, click the button below.

  • March 3, 2021

    The Heat Factor: Part 1 & 2:Why it Matters in Blow-Fill-Seal
    with Jeff Price, Consulting Principal BFS Engineer

    At ApiJect, our engineers have taken BFS filling enhancements even further by developing proprietary temperature control management methods that can potentially enable many temperature sensitive biologics and vaccines that are not possible on standard BFS lines.

Never miss an update

Social media & sharing icons powered by UltimatelySocial